EBR/AED (EBR/AED)

Euronext Brussels: EBR/AED · EUR

€63.6

+0.70 (+1.1%)· Recorded snapshot

Market cap	5.3B
Revenue (ttm)	485.4M
Net income (ttm)	640.9M
EPS (ttm)	€10.9
Shares out	83.5M
P/E (trailing)	5.8x
P/E (forward)	11.5x
Dividend	€4.20 (6.60%)
Volume	11,493
Beta	0.94

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 485.4M
Net income (ttm): 640.9M
EPS (ttm): €10.9
P/E (trailing): 5.8x
P/E (forward): 11.5x
Market cap: 5.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E11.5

P25 n/aP50 n/aP75 n/a

Trailing P/E5.8

P25 n/aP50 n/aP75 n/a

ROE12.2

P25 n/aP50 n/aP75 n/a

ROIC3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EBR/AED indicators

Market & fundamental data

Available fields

233

Groups with data

Currency

EUR

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Belgium
Country code	BE
Earnings date	2026-11-18
Employees	127
Employees change	-1
Employees growth	-0.78%
Enterprise value	EUR 11.4B
Exchange	Euronext Brussels
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2005
Industry	REIT - Healthcare Facilities
Is primary listing	Yes
ISIN number	BE0003851681
Last earnings date	2026-09-01
Last refreshed	2026-10-29
Market cap	EUR 5.3B
Next earnings date	2026-11-18
Price	EUR 63.60
Price currency	EUR
Sector	Real Estate
SIC code	6798
Stock price date	2026-10-29
Symbol	ebr/AED
Website	https://www.aedifica.eu

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	21.88x
Average P/E ratio (3Y)	29.89x
Average P/E ratio (5Y)	22.75x
Earnings yield	17.14%
EV/Earnings	17.77x
EV/EBIT	28.37x
EV/EBITDA	28.25x
EV/FCF	32.24x
EV/Sales	23.46x
FCF / EV yield	3.1%
FCF yield	6.73%
Forward P/E	11.51x
Graham number	137.32057
Graham upside	116.25%
Lynch fair value	EUR 272.56
Lynch upside	329.23%
P/B ratio	0.73x
P/E ratio	5.83x
P/FCF ratio	14.86x
P/OCF ratio	14.86x
P/S ratio	10.82x
PEG ratio	4.11x
Price / tangible book value	0.83x
Price/EBITDA ratio	13.02x
Sector forward P/E	11.14x
Sector P/E	9.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	82.71%
EBITDA margin	83.06%
Effective tax rate	6.05%
FCF margin	72.78%
Gross margin	91.75%
Operating margin	82.71%
Pretax margin	143.52%
Profit margin	132.03%
Profit per employee	EUR 5M
Profitable quarters	10
Profitable years	16
Revenue per employee	EUR 3.8M
ROA	2.57%
ROA (5Y)	2.77%
ROCE	3.62%
ROE	12.16%
ROE (5Y)	7.07%
ROIC	3%
ROIC (5Y)	4.2%
Tax / revenue	8.68%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	194.88%
EPS growth (Q)	-12.75%
EPS growth (QoQ)	-87.96%
EPS growth 10Y	12.72%
EPS growth 3Y	42.75%
EPS growth 5Y	11.55%
EPS growth years	2
Net income growth	264.53%
Net income growth (Q)	53.44%
Net income growth (QoQ)	-82.13%
Net income growth 3Y	62.44%
Net income growth 5Y	27.19%
Net income growth quarters	4
Net income growth years	2
OCF growth	21.02%
OCF growth 10Y	22.45%
OCF growth 3Y	12.81%
Revenue growth	34.32%
Revenue growth (Q)	104.29%
Revenue growth (QoQ)	56.54%
Revenue growth 10Y	23.31%
Revenue growth 3Y	17.22%
Revenue growth 5Y	19.64%
Revenue growth quarters	76
Revenue growth years	19

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -119,000
EBIT	EUR 401.5M
EBITDA	EUR 403.2M
EPS	EUR 10.90
FCF per share	EUR 4.23
Financing cash flow	EUR -227.8M
Free cash flow	EUR 353.3M
Gross profit	EUR 445.4M
Income taxes	EUR 42.1M
Investing cash flow	EUR -131.7M
Net cash flow	EUR -6.1M
Net income	EUR 640.9M
Operating income	EUR 401.5M
Revenue	EUR 485.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 76.87
Debt / EBITDA	13.38
Debt / equity	0.75
Debt / FCF	15.27
Goodwill	EUR 59.7M
Interest coverage	5.19
Net cash (debt)	EUR -5.3B
Net cash / market cap	-101.71%
Net debt / EBITDA	13.24
Net debt / equity	0.74
Net debt / FCF	15.11
Piotroski F-Score	3
Property, plant and equipment	EUR 12.4B
Shareholders' equity	EUR 7.2B
Tangible book value	EUR 6.4B
Tangible book value per share	EUR 76.13
Total assets	EUR 13.1B
Total cash	EUR 55.6M
Total debt	EUR 5.4B
Total liabilities	EUR 5.9B
WACC	5.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.05
Current ratio	0.13
Net working capital	EUR -8.7M
Quick ratio	0.08
Working capital	EUR -1.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-23.58%
Dividend growth	2.56%
Dividend growth (10Y)	6.21%
Dividend growth (3Y)	20.44%
Dividend growth (5Y)	9.21%
Dividend growth years	1
Dividend payment date	2026-05-19
Dividend payment years	20
Dividend payout frequency	Annual
Dividend per share	EUR 4.20
Dividend yield	6.6%
Ex-dividend date	2026-05-14
FCF payout ratio	66.15%
Last dividend	EUR 2.80
Payout ratio	59.36%
Shareholder yield	-16.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-15.71%
10Y return CAGR	3.25%
10Y total return	37.67%
150-day SMA	EUR 68.53
15Y price change	45.58%
15Y return CAGR	7.46%
15Y total return	194.35%
1D price change	1.11%
1M price change	-1.25%
1M total return	-1.25%
1W price change	-0.08%
1W total return	-0.08%
1Y price change	2.59%
1Y return CAGR	6.82%
1Y total return	6.82%
20-day SMA	EUR 62.35
200-day SMA	EUR 69.93
20Y price change	44.82%
20Y return CAGR	6.95%
20Y total return	283.13%
3M price change	-11.51%
3M total return	-11.51%
3Y price change	30.45%
3Y return CAGR	13.26%
3Y total return	45.31%
50-day SMA	EUR 64.80
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 80.05
52-week high date	2026-02-18
52-week low	EUR 60.35
52-week low date	2026-10-05
5Y price change	-46.09%
5Y return CAGR	-7.8%
5Y total return	-33.36%
6M price change	-12.91%
6M total return	-9.32%
All-time high	EUR 139.20
All-time high date	2020-02-19
All-time low	EUR 29.60
All-time low date	2008-10-08
Average true range (ATR)	EUR 0.92
Average volume	116.3K
Beta (1Y)	0.85
Beta (2Y)	0.57
Beta (5Y)	0.94
Change from 52-week high	-20.55%
Change from 52-week low	5.39%
Change from all-time high	-54.45%
Change from all-time low	114.19%
Change from open	1.27%
Day's gap	-0.16%
Dollar volume	EUR 730,955
High price	EUR 63.60
Low price	EUR 62.60
Monthly RSI	44.41
Open price	EUR 62.80
Position in 52-week range	100%
Previous close	EUR 62.90
Price vs 150-day SMA	-7.48%
Price vs 20-day SMA	1.69%
Price vs 200-day SMA	-9.33%
Price vs 50-day SMA	-2.15%
Relative volume	0.1
RSI	50.29
Sharpe ratio	0.11
Sharpe ratio (3Y)	0.26
Sharpe ratio (5Y)	-0.39
Sortino ratio	0.5
Sortino ratio (3Y)	0.67
Sortino ratio (5Y)	-0.32
Volume	11.5K
Weekly RSI	39.96
YTD price change	-6.07%
YTD total return	-2.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	48.45%
Shares change (YoY)	23.58%
Shares held by institutions	31.14%
Shares outstanding	83.5M

Deeper analysis on EBR/AED

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this EBR/AED report

Is a complete EBR/AED research report available?

No complete published report is available for ebr/AED (EBR/AED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

EBR/AED (EBR/AED)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/AED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/AED indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/AED

Frequently asked questions